Intercept Pharmaceuticals, Inc.

TWO SIGMA ADVISERS, LP

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

146,200

Value ($000)

2,711

Weight

0.0%

2014 Q1 - 2023 Q3 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	2,711	0.0%	146,200	9/30/2023
2023 Q2	8/14/2023	1,477	0.0%	133,500	6/30/2023
2023 Q1	5/15/2023	6,687	0.0%	497,900	3/31/2023
2022 Q4	2/14/2023	6,747	0.0%	545,400	12/31/2022
2022 Q3	11/14/2022	8,818	0.0%	632,100	9/30/2022
2022 Q2	8/15/2022	6,115	0.0%	442,800	6/30/2022
2022 Q1	5/16/2022	9,391	0.0%	577,200	3/31/2022
2021 Q4	2/14/2022	8,953	0.0%	549,600	12/31/2021
2021 Q3	11/15/2021	6,726	0.0%	452,900	9/30/2021
2021 Q2	8/16/2021	9,937	0.0%	497,600	6/30/2021
2021 Q1	5/17/2021	7,409	0.0%	321,000	3/31/2021
2020 Q4	2/16/2021	10,013	0.0%	405,400	12/31/2020
2020 Q3	11/16/2020	24,039	0.1%	579,800	9/30/2020
2020 Q2	9/15/2020	24,688	0.1%	515,300	6/30/2020
2020 Q1	5/15/2020	33,973	0.1%	539,600	3/31/2020
2019 Q4	2/14/2020	48,626	0.1%	392,400	12/31/2019
2014 Q1	5/15/2014	363	0.0%	1,100	3/31/2014